经口腔前庭入路与微创非内镜甲状腺切除术的倾向匹配队列比较
该倾向匹配队列研究纳入720例接受肿瘤整形甲状腺切除术的患者,匹配后各210例,比较TOETVA与MINET。TOETVA手术时间更长、费用更高、标本破损更常见,但术中神经监测警报和误切甲状旁腺更少,术后第1天疼痛评分略高。结论支持需谨慎选择患者并进一步前瞻性评估。
要点
- TOETVA手术时间更长、总费用更高,标本破损风险更高。
- TOETVA术中神经监测警报和误切甲状旁腺更少。
- TOETVA术后第1天疼痛评分略高,需谨慎选择患者。
核心结论
- TOETVA与更好的美容效果、神经和甲状旁腺保护相关,但手术时间更长、费用更高、标本破损风险更大。
研究设计与样本
- 倾向匹配队列研究,纳入2021年1月至2023年1月在台湾台北三级转诊中心接受肿瘤整形甲状腺切除术的720例患者,随访12个月。
- 倾向评分匹配后形成各210例的平衡队列,共420例匹配患者,平均年龄45.6岁(SD 12.3),女性371例(88.3%)。
主要发现
- TOETVA平均手术时间127.9分钟(SD 43.8) vs MINET 68.1分钟(SD 23.3),平均差59.73分钟(95%CI 53.20-66.26,P<.001)。
- TOETVA术中神经监测警报4/255(1.6%) vs MINET 13/262(5.0%),风险差-3.39%(95%CI -6.54至0.08,P=.04)。
- TOETVA误切甲状旁腺24/510(4.7%) vs MINET 57/524(10.9%),风险差-6.17%(95%CI -9.42至-2.85,P<.001)。
- TOETVA术后第1天VAS疼痛评分平均0.88(SD 0.22) vs MINET 0.38(SD 0.13),平均差0.50(95%CI 0.47-0.54,P<.001)。
- TOETVA标本破损27/210(12.9%) vs MINET 8/210(3.8%),风险差9.05%(95%CI 3.52-14.28,P=.008);总费用平均4680美元(SD 328) vs 2734美元(SD 296),平均差1946美元(95%CI 1885.19-2006.87,P<.001)。
临床怎么用
- 临床选择TOETVA时应权衡美容获益与更长手术时间、更高费用及标本破损风险。
- TOETVA可能有利于神经和甲状旁腺保护,但需注意术后疼痛略高。
局限性
- 本研究为倾向匹配队列研究,存在残余混杂可能。
- 单中心研究,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The transoral endoscopic thyroidectomy vestibular approach (TOETVA) is a scarless surgical technique gaining popularity; however, its safety, cost, and impact on pathological evaluation compared with minimally invasive nonendoscopic thyroidectomy (MINET) remain under evaluation. OBJECTIVE: To compare surgical outcomes, pathological considerations, and cost profiles following TOETVA vs MINET using a propensity-matched cohort. DESIGN, SETTING, AND PARTICIPANTS: This cohort study included 720 patients undergoing oncoplastic thyroidectomy between January 2021 and January 2023, with 12-month follow-up, at a tertiary referral center in Taipei, Taiwan. Propensity score matching was used to generate balanced cohorts of 210 patients each. MAIN OUTCOMES AND MEASURES: Primary outcomes included operative duration (measured from incision to closure), intraoperative neuromonitoring (IONM) alerts (recorded in real time via standard IONM systems), parathyroid preservation (assessed by identification and in situ preservation), postoperative pain (evaluated using the visual analog scale [VAS] score on postoperative day 1), specimen integrity (as documented in final pathology reports), postoperative complications, and overall cost (derived from itemized hospital billing records). RESULTS: Among 420 matched patients (mean age [SD], 45.6 [12.3] years; 371 [88.3%] female), TOETVA was associated with longer mean (SD) operative time (127.9 [43.8] vs 68.1 [23.3] minutes; mean difference, 59.73 minutes; 95% CI, 53.20-66.26; P < .001), fewer IONM alerts (4/255 [1.6%] vs 13/262 [5.0%]; risk difference, -3.39%; 95% CI, -6.54 to 0.08; P = .04), and fewer inadvertently resected parathyroid glands (24/510 [4.7%] vs 57/524 [10.9%]; risk difference, -6.17%; 95% CI, -9.42 to -2.85; P < .001). Pain scores were slightly higher in TOETVA (mean [SD] VAS score: 0.88 [0.22] vs 0.38 [0.13]; mean difference, 0.50; 95% CI, 0.47-0.54; P < .001). Specimen disruption was more frequent with TOETVA (27/210 [12.9%] vs 8/210 [3.8%]; risk difference, 9.05%; 95% CI, 3.52 to 14.28; P = .008). Total costs were higher in TOETVA (mean [SD], $4680 [328] vs $2734 [296]; mean difference, $1946; 95% CI, 1885.19 to 2006.87; P < .001). CONCLUSIONS AND RELEVANCE: In this propensity-matched cohort study, TOETVA was associated with favorable cosmetic outcomes and improved nerve and parathyroid preservation but longer operative times, higher costs, and greater risk of specimen disruption. These findings support the need for careful patient selection and further prospective evaluation.
引用
- Kuo TC, Chen KY, Lai CW, et al. Transoral Endoscopic and Minimally Invasive Thyroidectomy. JAMA Surg. 2025. PMID: 40900567. doi:10.1001/jamasurg.2025.3248
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。